Expression of IL-10-triggered STAT3-dependent IL-4Rα is required for induction of arginase 1 in visceral leishmaniasis

European Journal of Immunology

Volumn 41, Issue 4, 2011, Pages 992-1003

  Biswas, Arunima ^a   Bhattacharya, Arijit ^b   Kar, Susanta ^a   Das, Pijush K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b PRESIDENCY UNIVERSITY   (India)

Author keywords

Arginase 1; IL 10; IL 4; IL 4 receptor ; Visceral leishmaniasis

Indexed keywords

ARGINASE 1; CCAAT ENHANCER BINDING PROTEIN BETA; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; STAT3 PROTEIN; STAT6 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOKINE PRODUCTION; DISEASE COURSE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; LEISHMANIA DONOVANI; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPLEEN CELL; TH2 CELL; VISCERAL LEISHMANIASIS;

ANIMALS; ARGINASE; CELLS, CULTURED; INTERLEUKIN-10; LEISHMANIASIS, VISCERAL; MICE; MICE, INBRED BALB C; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; STAT3 TRANSCRIPTION FACTOR; TH2 CELLS;

EID: 79953045226     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040940     Document Type: Article

References (42)

1. Jenkinson, C. P., Grody, W. W. and Cederbaum, S. D., Comparative properties of arginases. Comp. Biochem. Physiol. Biochem. Mol. Biol. 1996. 114: 107-132.
2. Modolell, M., Corraliza, I. M., Link, F., Soler, G. and Eichmann, K., Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur. J. Immunol. 1995. 25: 1101-1104.
3. Wei, L. H., Jacobs, A. T., Morris, S. M., Jr., and Ignarro, L. J., IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2000. 279: 248-256.
4. Giordanengo, L., Guiñazú, N., Stempin, C., Fretes, R., Cerbán, F. and Gea, S., Cruzipain, a major Trypanosoma cruzi antigen, conditions the host immune response in favor of parasite. Eur. J. Immunol. 2002. 32: 1003-1011.
5. Abdallahi, O. M. S., Bensalem, H., Augier, R., Daigana, M., De Reggi, M. and Gharib, B., Arginase expression in peritoneal macrophages and increase in circulating polyamine levels in mice infected with Schistosoma mansoni. Cell. Mol. Life Sc. 2001. 58: 1350-1357.
6. Chakravortty, D. and Hensel, M., Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect. 2003. 5: 621-627.
7. Lahiri, A., Das, P. and Chakravortty, D., Arginase modulates Salmonella induced nitric oxide production in RAW264.7 macrophages and is required for Salmonella pathogenesis in mice model of infection. Microbes Infect. 2008. 10: 1166-1174.
8. Gobert, A. P., Cheng, Y., Wang, J. Y., Boucher, J. L., Iyer, R. K., Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J. Immunol. 2002. 168: 4692-4700.
9. Iniesta, V., Gomez-Nieto, L. C., Molano, I., Mohedano, A., Carcelen, J., Miron, C., Alonso, C. et al., Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites. Parasite Immunol. 2002. 24: 113-118.
10. Rogers, K. A., Dekrey, G. K., Mbow, M. L., Gillespie, R. D., Brodskyn, C. I. and Titus, R. G., Type 1 and type 2 responses to Leishmania major. FEMS Microb. Lett. 2002. 209: 1-7.
11. Anderson, C. F., Oukka, M., Kuchroo, V. J. and Sacks, D., CD4(+)CD25(2) Foxp3(2) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 2007. 204: 285-297.
12. Noben-Trauth, N., Kropf, P. and Müller, I., Susceptibility to Leishmania major infection in interleukin-4 deficient mice. Science 1996. 271: 987-990.
13. Mosser, D. M., The many faces of macrophage activation. J. Leukoc. Biol. 2003. 73: 209-212.
14. Wu, G., Morris, S. M., Jr., Arginine metabolism: nitric oxide and beyond. Biochem. J. 1998. 336: 1-17.
15. Iniesta, V., Carcelen, J., Molano, L., Peixoto, P. M. V., Redondo, E., Parra, P., Mangas, M. et al., Arginase I induction during Leishmania major infection mediates the development of disease. Infect. Immun. 2005. 73: 6085-6090.
16. Kropf, P., Fuentes, J. M., Fähnrich, E., Arpa, L., Herath, S., Weber, V., Germán Soler, U. et al., Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. FASEB J. 2005. 19: 1000-1002.
17. Rutschman, R., Lang, R., Hesse, M., Ihle, J. N., Wynn, T. A. and Murray, P. J., Cutting edge: stat6-dependent substrate depletion regulates nitric oxide production. J. Immunol. 2001. 166: 2173-2177.
18. Gray, M. J., Poljakovic, M., Kepka-Lenhart, D. and Sidney, M. M., Jr., Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPβ. Gene 2005. 353: 98-106.
19. Keats, N., Achsah, D., Keegan, C., José Zamorano, C., Ryan, J. J. and Paul, W. E., The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 1999. 17: 701-738.
20. Lang, R., Patel, D., Morris, J. J., Rutschman, R. L. and Murray, P. J., Shaping gene expression in activated and resting primary macrophages by IL-10. J. Immunol. 2002. 169: 2253-2263.
21. El Kasmi, K. C., Qualls, J. E., Pesce, J. T., Smith, A. M., Thompson, R. W., Henao-Tamayo, M., Basaraba, R. J. et al., Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 2008. 9: 1399-1406.
22. Reguera, R. M., Balãna-Fouce, R., Showalter, M., Hickerson, S., Beverley, S. M., Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB/c mice. Mol. Biochem. Parasitol. 2009. 165: 48-56.
23. Gaur, U., Roberts, S. C., Dalvi, R. P., Corraliza, I., Ullman, B. and Wilson, M. E., An effect of parasite-encoded arginase on the outcome of murine cutaneous leishmaniasis. J. Immunol. 2007. 179: 8446-8453.
24. Osorio, Y. E., Zhao, W., Espitia, C., Travi, B. L., Hawel, L., Byus, C. V., Saldarriaga, O. A. and Melby, P. C., Dominant arginase expression in a model of progressive visceral leishmaniasis. FASEB J. 2008. 22: 860.20.
25. ω hydroxy-L-arginine controls the growth of Leishmania inside macrophages. J. Exp. Med. 2001. 193: 777-784.
26. Alexander, J. and Bryson, K., T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol. Lett. 2005. 99: 17-23.
27. Murphy, M. L., Wille, U., Villegas, E. N., Hunter, C. A., Farrell, J. P., IL-10 mediates susceptibility to Leishmania donovani infection. Eur. J. Immunol. 2001. 31: 2848-2856.
28. Munder, M., Eichmann, K., Morán, J. M., Centeno, F., Soler, G. and Modolell, M., Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 1999. 163: 3771-3777.
29. + T cells correlates with Th1/Th2 phenotype. J. Immunol. 1998. 160: 534-537.
30. Lewis, N. D., Asim, M., Barry, D. P., Singh, K., de Sablet, T., Boucher, J.-L., Gobert, A. P. et al., Arginase II restricts host defense to Helicobacter pylori by attenuating inducible nitric oxide synthase translation in macrophages. J. Immunol. 2010. 184: 2572-2582.
31. Noben-Trauth, N., Paul, W. E. and Sacks, D. L., IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J. Immunol. 1999. 162: 6132-6140.
32. Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Forster, I. and Akira, S., Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of stat3 in macrophages and neutrophils. Immunity 1999. 10: 39-49.
33. Butcher, B. A., Kim, L., Panopoulos, A. D., Watowich, S. S., Murray, P. J. and Denkers, E. Y., IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-α in host macrophages. J. Immunol. 2005. 174: 3148-3152.
34. Lin, T. and Bost, K. L., STAT3 activation in macrophages following infection with Salmonella. Biochem. Biophys. Res. Commun. 2004. 321: 828-834.
35. Ukil, A., Biswas, A., Das, T. and Das, P. K., 18β-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-κB. J. Immunol. 2005. 175: 1161-1169.
36. Kar, S., Ukil, A. and Das, P. K., Signaling events leading to the curative effect of cystatin on experimental visceral leishmaniasis: involvement of ERK1/2, NF-kappaB and JAK/STATpathways. Eur. J. Immunol. 2009. 39: 741-751.
37. Sarkar, K. and Das, P. K., Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines. J. Immunol. 1997. 158: 5357-5365.
38. Das, L., Datta, N., Bandyopadhyay, S. and Das, P. K., Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favourable T-cell response. J. Immunol. 2001. 166: 4020-4028.
39. Kar, S., Ukil, A., Sharma, G. and Das, P. K., MAPK-directed phosphatases preferentially regulate pro- and anti-inflammatory cytokines in experimental visceral leishmaniasis: involvement of distinct protein kinase C isoforms. J. Leukoc. Biol. 2010. 88: 9-20.
40. Corraliza, I. M., Campo, M. L., Soler, G. and Modelell, M., Determination of arginase activity in macrophages: a micromethod. J. Immunol. Methods 1994. 174: 231-235.
41. Bhattacharya, A., Biswas, A. and Das, P. K., Role of intracellular cAMP in differentiation-coupled induction of resistance against oxidative damage in Leishmania donovani. Free Radic. Biol. Med. 2008. 44: 779-794.
42. Pauleau, A. L., Rutschman, R., Lang, R., Pernis, A., Watowich, S. S. and Murray, P. J., Enhancer-mediated control of macrophage-specific arginase I expression. J. Immunol. 2004. 172: 7565-7573.